Please login to the form below

Not currently logged in
Email:
Password:

Sun Pharma

This page shows the latest Sun Pharma news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca launches $1bn Chinese investment fund

AstraZeneca launches $1bn Chinese investment fund

As the world’s second-largest healthcare market after the US, China has been a target for many big pharma companies, and AstraZeneca is already among the multinational drug industry’s  ... At the same time, AZ has just announced a partnership with

Latest news

More from news
Approximately 6 fully matching, plus 43 partially matching documents found.

Latest Intelligence

  • Deal Watch December 2016 Deal Watch December 2016

    295. Novartis (Switzerland). Sun Pharma (India). Asset acquisition. Odomzo (sonidegib; hedgehog pathway inhibitor), approved in basal cell carcinoma. ... Sun Pharma. 3.5%. BSN Medical. Svenska Cellulosa. -0.7%. Claris. Baxter. -1.3%.

  • Deal Watch November 2016 Deal Watch November 2016

    Sun Pharma will also assume Biosintez's $36m debt as part of this transaction. ... acquisition - company. 78. JSC Biosintez/ Sun Pharma. Russian pharma focusing on hospital segment with 2015 revenues of approx $52m.

  • Choosing destiny Choosing destiny

    to, for example, Sun Pharma and vice-versa.

  • Deal Watch July 2016 Deal Watch July 2016

    In at numbers 2, 3 and 4 are the LEO-AstraZeneca deal with an upfront of $115m, Astellas-Cytokinetics at $95m and Almirall-Sun Pharma at $50m (see below). ... Almirall paid $50m upfront to Sun Pharma for a licence to tildrakizumab (an IL-23p19 antibody)

  • Pharma deals during April 2014 Pharma deals during April 2014

    may not be as simple as it seems. Last year the FDA imposed export bans from 20 or so plants in India and warned several others, and whilst Sun Pharma has ... is rumoured that a solution will be to replace the Ranbaxy brand with the Sun Pharma moniker

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Health editor at The Sun newspaper joins Ruder Finn Health editor at The Sun newspaper joins Ruder Finn

    Emma Morton appointed media strategist at PR firm. Emma Morton, health and science editor at UK newspaper The Sun,  is to join the London healthcare team of communications firm Ruder Fin ... Morton spent 13 years at The Sun, initially joining as a

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • How To Become an MSL – Online Training

    Michael Milane, MD, MBA DUSA Pharmaceuticals, a SUN Pharma company . Executive Director of Medical Affairs Jennifer Williams, PhD, JD, MBA, MS, RN Bard Medical Director of Medical Science Liaisons.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
claire@dovetailstrategies.com

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...

Infographics